Please login to the form below

Not currently logged in
Email:
Password:

Jörg Reinhardt - new CEO Bayer Healthcare

Bayer has announced that Dr Jörg Reinhardt, former chief operating officer of Novartis, is to replace Arthur Higgins as Bayer Healthcare CEO

Dr Jörg Reinhardt, former chief operating officer of Novartis, has been appointed chairman of the board of management of Bayer Healthcare and chairman of the Bayer Healthcare executive committee with effect from August 15, 2010. 

Commenting on the new appointment, Werner Wenning, chairman of the board of management of Bayer AG said: "Dr Reinhardt is an acknowledged expert with many years of experience in the healthcare industry."

"We are convinced of his ability to provide a decisive impetus to our global healthcare business and further expand our strong competitive positions," he continued.

Martin J Higgins and Dr Jörg Reinhardt, Bayer Healthcare  

Outgoing CEO Arthur J Higgins (left) and Dr Jörg Reinhardt 

Current healthcare CEO, Arthur J Higgins, will leave the company on April 30 at his own request.

Dr Marijn Dekkers, member of the Bayer AG board of management and its designated chairman, will take over as head of Bayer Healthcare on a temporary basis from May 1, 2010 until Dr Reinhardt's appointment takes effect.

21st April 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics